In this chapter, we are learning about non-communicable diseases
(non-infectious), screening related to cost-effectiveness and
efficacy, and the associated burden. Questions to ponder are what
makes a screening program efficacious? What part does the physician
and/or patient play in early detection? What is the cost of
pre-testing and has the screening had an effective on health
outcomes? Please select two questions below.
Discuss the burden of non-communicable diseases on mortality and
morbidity in the United States.
Discuss the ideal criteria...
Although infectious disease control and emergency
preparedness remain vital to the public’s health, non-communicable
diseases (NCDs) and injuries are now the leading causes of
disability and premature death.
Cancer and diabetes are NCDs that are responsible for
more than 50% of deaths worldwide, making them the leading cause of
mortality in the world. As the global health community works to
find solutions to these illnesses, it is important to recognize
that these diseases can come in a variety of forms...
When insurance companies establish policies for covering screening tests for diseases, one important factor is the value of the test predicting the disease. For example, for a certain type of disease, insurance companies may only cover the test costs if the test improves the prediction of having the disease by 90%. To help decide coverage policy for a new test, use the following data to help decide whether the test should be covered. What is your conclusion? Justify your answer.
Using your text or online resources, what is the difference
between communicable and non-communicable disease? What are the
differences in the way we treat or prevent these two types of
disease? What do you think is the most threatening communicable
Disease? What do you think is the most threatening non-communicable
disease
Apply the epidemiology triangle to the following communicable
diseases: Tuberculosis
Identify the host, agent, and environment for tuberculosis
What is/are the route(s) of transmission?
What type of immunity is obtained, if any?
Describe CHN interventions at the primary, secondary, and
tertiary level.
What are the barriers to controlling tuberculosis and how can a
P/CHN intervene?
Identify and post an evidenced-based infographic on
tuberculosis
Could someone please assist me with the following: Thanks!
Briefly describe the burden of non-communicable diseases (NCD)
on mortality and morbidity in the United States currently.
What are the necessary criteria needed for a sound screening
program?